We are live on ! Find out more
IHI icon

iShares US Medical Devices ETF

662 hedge funds and large institutions have $3.56B invested in iShares US Medical Devices ETF in 2021 Q4 according to their latest regulatory filings, with 128 funds opening new positions, 231 increasing their positions, 188 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 128 | Existing positions closed: 32

23% more repeat investments, than reductions

Existing positions increased: 231 | Existing positions reduced: 188

22% more funds holding in top 10

Funds holding in top 10: 2328 (+5)

15% more funds holding

Funds holding: 574662 (+88)

13% more capital invested

Capital invested by funds: $3.14B → $3.56B (+$419M)

2.06% more ownership

Funds ownership: 37.27%39.33% (+2.1%)

9% more call options, than puts

Call options by funds: $13.7M | Put options by funds: $12.5M

Holders
662
Holders Change
+88
Holders Change %
+15.33%
% of All Funds
10.19%
Holding in Top 10
28
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+21.74%
% of All Funds
0.43%
New
128
Increased
231
Reduced
188
Closed
32
Calls
$13.7M
Puts
$12.5M
Net Calls
+$1.12M
Net Calls Change
+$114K
Name Holding Trade Value Shares
Change
Change in
Stake
SFM
401
Signet Financial Management
New Jersey
$468K +$70.6K +1,103 +18%
SCFS
402
S.C. Financial Services
Arizona
$467K +$483K +7,538 New
BA
403
Ballast Advisors
Minnesota
$466K +$1.34K +21 +0.3%
TI
404
Trexquant Investment
Connecticut
$466K +$453K +7,084 New
WWM
405
Western Wealth Management
Colorado
$466K +$454K +7,088 New
CMS
406
Capital Market Strategies
Florida
$465K +$452K +7,055 New
SS
407
Simplicity Solutions
Minnesota
$464K +$452K +7,056 New
WPC
408
Wedmont Private Capital
Pennsylvania
$463K +$478K +7,473 New
Renaissance Technologies
409
Renaissance Technologies
New York
$461K -$173K -2,700 -28%
WIA
410
World Investment Advisors
California
$460K +$13.9K +217 +3%
ATPW
411
Ashton Thomas Private Wealth
Arizona
$454K +$442K +6,900 New
SFP
412
Sandbox Financial Partners
Maryland
$454K -$32.5K -507 -7%
WANY
413
Wealthspire Advisors (New York)
New York
$452K -$2.31K -36 -0.5%
GTCM
414
Gyon Technologies Capital Management
New Jersey
$452K +$440K +6,866 New
EVM
415
Eaton Vance Management
Massachusetts
$445K +$29.9K +467 +7%
KPCM
416
Kings Point Capital Management
New York
$444K +$36.8K +575 +9%
IF
417
Intrua Financial
Texas
$443K -$17.1K -267 -4%
MWM
418
MBE Wealth Management
Wisconsin
$442K -$64.6K -1,009 -13%
SL
419
SWMG LLC
Texas
$441K +$98.5K +1,538 +30%
FFWM
420
Future Financial Wealth Management
Ohio
$440K +$359K +5,605 +500%
MSCM
421
McElhenny Sheffield Capital Management
Texas
$437K
CWM
422
Campbell Wealth Management
Virginia
$436K +$84.8K +1,325 +25%
SPFA
423
Summit Place Financial Advisors
New Jersey
$431K -$32.6K -510 -7%
SFI
424
SPC Financial Inc
Maryland
$420K
FAP
425
Financial Advisory Partners
Florida
$415K +$403K +6,300 New

IHI Hedge Fund Activity: Q4 2021 in Review

662 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in iShares US Medical Devices ETF (IHI) for Q4 2021, worth a combined $3.56B — up 13% from $3.14B a quarter earlier.

Buyers outnumbered sellers: 128 funds opened new IHI positions and 32 closed out — a net gain of 96 holders — while 231 added to existing stakes and 188 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $36.3M. The largest seller was Marks Wealth, exiting entirely with an estimated $33.2M sold.

  • 662 institutional investors held iShares US Medical Devices ETF (IHI) as of Q4 2021, up from 574 in Q3 2021.
  • Funds reported $3.56B of iShares US Medical Devices ETF stock for Q4 2021, up 13% quarter-over-quarter.
  • 128 funds opened new iShares US Medical Devices ETF positions in Q4 2021 and 32 closed out, a net change of +96 holders.
  • The largest iShares US Medical Devices ETF buyer in Q4 2021 was Morgan Stanley, an estimated $36.3M added.
  • The largest iShares US Medical Devices ETF seller in Q4 2021 was Marks Wealth, an estimated $33.2M sold.

Based on aggregated 13F filings for Q4 2021.